Transcriptional Characterization of Glioma Neural Stem Cells Diva ...

[38] G. Bain, D. Kitchens, M. Yao, J. Huettner, and D. Gottlieb. Embryonic stem cells
express neuronal properties in vitro. Developmental biology, 168(2):342–357, 1995.
[39] L. Balenci. IQGAP1 Protein Specifies Amplifying Cancer Cells in Glioblastoma Multiforme.
Cancer Research, 66(18):9074–9082, Sept. 2006.
[40] S. Bao, Q. Wu, R. McLendon, Y. Hao, Q. Shi, A. Hjelmeland, M. Dewhirst, D. Bigner,
and J. Rich. Glioma stem cells promote radioresistance by preferential activation of
the DNA damage response. Nature, 444(7120):756–760, 2006.
[41] I. Barani, S. Benedict, and P. Lin. Neural stem cells: implications for the conventional
radiotherapy of central nervous system malignancies. International Journal of
Radiation Oncology* Biology* Physics, 68(2):324–333, 2007.
[42] J. Barnes and P. Hut. A hierarchical 0 (n log iv) force-calculation algorithm. nature,
324:4, 1986.
[43] D. P. Bartel. MicroRNAs: target recognition and regulatory functions. Cell,
136(2):215–33, 2009.
[44] N. Baumann. Biology of oligodendrocyte and myelin in the mammalian central nervous
system. Physiological Reviews, 2001.
[45] A. Bellacosa, C. C. Kumar, A. Di Cristofano, and J. R. Testa. Activation of AKT
kinases in cancer: implications for therapeutic targeting. Advances in cancer research,
94:29–86, 2005.
[46] A. Bellacosa, J. R. Testa, R. Moore, and L. Larue. A portrait of AKT kinases: human
cancer and animal models depict a family with strong individualities. Cancer biology
& therapy, 3(3):268–275, Mar. 2004.
[47] D. R. Bentley. Whole-genome re-sequencing. Current opinion in genetics and development,
16(6):545–52, 2006.
[48] I. Bentwich. Prediction and validation of micrornas and their targets. FEBS letters,
579(26):5904–5910, 2005.
[49] R. Berg, E. Leung, S. Gough, C. Morris, W. Yao, S. Wang, J. Ni, and G. Krissansen.
Cloning and characterization of a novel-beta integrin-related cdna coding for the protein
tied. Genomics, 56(2):169–178, 1999.
[50] R. Berg, E. Leung, S. Gough, C. Morris, W. Yao, S. Wang, J. Ni, and G. Krissansen.
Cloning and characterization of a novel β integrin-related cdna coding for the protein
tied (ÂŞten β integrin egf-like repeat domainsÂŤ) that maps to chromosome band
13q33: a divergent stand-alone integrin stalk structure. Genomics, 56(2):169–178,
1999.
[51] A. Bergamaschi, Y. Kim, K. Kwei, Y. La Choi, M. Bocanegra, A. Langerød, W. Han,
D. Noh, D. Huntsman, S. Jeffrey, et al. Camk1d amplification implicated in epithelialmesenchymal
transition in basal-like breast cancer. Molecular oncology, 2(4):327–339,
2008.
[52] R. Beroukhim, G. Getz, L. Nghiemphu, J. Barretina, T. Hsueh, D. Linhart, I. Vivanco,
J. Lee, J. Huang, S. Alexander, et al. Assessing the significance of chromosomal
aberrations in cancer: methodology and application to glioma. Proceedings of the
National Academy of Sciences, 104(50):20007–20012, 2007.
[53] M. Berry, Z. Ahmed, B. Lorber, M. Douglas, and A. Logan. Regeneration of axons in
the visual system. Restorative neurology and neuroscience, 26(2):147–174, 2008.
[54] F. Bertucci, P. Finetti, N. Cervera, E. Charafe-Jauffret, E. Mamessier, J. Adélaïde,
S. Debono, G. Houvenaeghel, D. Maraninchi, P. Viens, et al. Gene expression profiling
shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Research,
66(9):4636–4644, 2006.
[55] M. Bibel, J. Richter, K. Schrenk, K. Tucker, V. Staiger, M. Korte, M. Goetz, and
Y. Barde. Differentiation of mouse embryonic stem cells into a defined neuronal lineage.
Nature neuroscience, 7(9):1003–1009, 2004.
[56] L. Biesecker. Exome sequencing makes medical genomics a reality. Nature genetics,
42(1):13, 2010.